Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Transdiagnostic Oncology Program (TOP): a Combined Lifestyle Intervention to Improve the Quality of Life of Cancer Survivors - a Before-and-after Pilot Study in Primary Care

NCT06809452 is registered in ClinicalTrials.gov with Lentis Psychiatric Institute as lead sponsor.

NCT NCT06809452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Transdiagnostic Oncology Program (TOP): a Combined Lifestyle Intervention to Improve the Quality of Life of Cancer Survivors - a Before-and-after Pilot Study in Primary Care
Lead sponsor
Lentis Psychiatric Institute
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
January 1, 2020
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer survivor